About One Clinical Research
Clinical Trials at One Clinical Research
During the past decade, One Clinical Research conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "One Clinical Research" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "Antengene Therapeutics Limited" with 1 trials
sponsored, "Bio-Thera Solutions" with 1 trials sponsored, "Constellation Pharmaceuticals" with 1 trials sponsored and "EpimAb Biotherapeutics (Suzhou)Co., Ltd."
with 1 trials sponsored. Other sponsors include 1 different institutions and
companies that sponsored additional 11 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "One Clinical Research"
#1 collaborator was "Merck Sharp & Dohme LLC" with 2 trials as a collaborator and "George Clinical Pty Ltd" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at One Clinical Research
According to Clinical.Site data, the most researched conditions in "One Clinical Research" are
"Advanced Solid Tumor" (1 trials), "Advanced Solid Tumors" (1 trials), "Advanced/Metastatic Solid Tumors" (1 trials), "B Cell NHL" (1 trials) and "CLL" (1 trials). Many other conditions were trialed in "One Clinical Research" in a lesser frequency.
Clinical Trials Intervention Types at One Clinical Research
Most popular intervention types in "One Clinical Research" are "Drug" (9 trials), "Biological" (3 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "ATG-037" (1 trials), "Alectinib" (1 trials), "An Anti-PD-1 Antibody" (1 trials), "BAT7104" (1 trials) and "Durvalumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at One Clinical Research
The vast majority of trials in "One Clinical Research" are
13 trials for "All" genders.
Clinical Trials Status at One Clinical Research
Currently, there are NaN active trials in "One Clinical Research".
undefined are not yet recruiting,
12 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in One Clinical Research,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in One Clinical Research, 8 "Phase 1"
clinical trials were conducted, 8 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".